Lind Kevin Robert 4
4 · Longboard Pharmaceuticals, Inc. · Filed Nov 13, 2024
Insider Transaction Report
Form 4
Lind Kevin Robert
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-11-13$3.12/sh+12,808$40,002→ 443,740 total - Gift
Common Stock
2024-11-13−80,000→ 363,740 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-13−12,808→ 255,377 totalExercise: $3.12Exp: 2030-10-26→ Common Stock (12,808 underlying)
Footnotes (3)
- [F1]Represents a cash exercise of vested stock options without a subsequent sale of the underlying shares of common stock.
- [F2]Represents shares of common stock gifted to a donor-advised trust.
- [F3]The shares subject to the stock option vested and became exercisable in 24 equal monthly installments commencing November 27, 2022.